BlackRock Japan’s AMAG Pharmaceuticals AMAG Stock Holding History

BlackRock Japan’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-323	Closed	-$8K	–	1461
2016 Q2	$8K	Sell	323 -701	-68%	-$16.1K	﹤0.01%	1300
2016 Q1	$24K	Buy	1,024 +235	+30%	+$5.58K	﹤0.01%	1162
2015 Q4	$24K	Buy	+789	New	+$25.5K	﹤0.01%	1141
2014 Q2	–	Sell	-2,917	Closed	-$56K	–	1439
2014 Q1	$56K	Buy	+2,917	New	+$62K	﹤0.01%	1153
2013 Q4	–	Sell	-3,527	Closed	-$76K	–	1445
2013 Q3	$76K	Buy	3,527 +1,688	+92%	+$39.9K	﹤0.01%	1045
2013 Q2	$41K	Buy	+1,839	New	+$40.5K	﹤0.01%	1134

Other funds holding AMAG

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

SIM

Stelliam Investment Management New York $404M AUM 5.1% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

BlackRock Japan's AMAG Position: Q3 2016 in Review

BlackRock Japan sold out of AMAG Pharmaceuticals (AMAG) in Q3 2016, closing a stake of 323 shares — an estimated $8K sold.

BlackRock Japan first reported a position in AMAG in Q2 2013 and held it in 6 quarters. The position peaked at $76K in Q3 2013. 178 funds tracked by Wall St. Rank hold AMAG as of Q3 2016.

BlackRock Japan reported no remaining AMAG Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
BlackRock Japan sold 323 AMAG Pharmaceuticals shares in Q3 2016, an estimated $8K.
BlackRock Japan first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 6 quarters.
BlackRock Japan's AMAG Pharmaceuticals position peaked at $76K in Q3 2013.
178 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2016.

Based on BlackRock Japan's 13F filing for Q3 2016, filed 8 Nov 2016.